RECCE PHARMACEUTICALS LTD — Major Shareholding Notification 2020

Sep 29, 2020

604 Page 1 of 3 15 July 2001

Form 604

Corporations Act 2001

Section 671B

Notice of change of interests of substantial holder

To Company Name/Scheme Recce Pharmaceuticals Ltd

ACN/ARSN 124 849 065

1. Details of substantial holder (1)

Name Graham John Melrose & Olga Mary Melrose

ACN/ARSN (if applicable)

There was a change in the interests of the substantial holder on

substantial holder on 30 / 09 / 2020 The previous notice was given to the company on 10 / 07 / 2020 The previous notice was dated 10 / 07 / 2020

2. Previous and present voting power

The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in when last required, and when now required, to give a substantial holding notice to the company or scheme, are as follows:

ompany or scheme, are as follows:
Class of securities (4)	Previous notice		Present notice
	Person’s votes	Voting power(5)	Person’s votes	Voting power(5)
ORDINARY SHARES	36,450,003	25.28%	40,948,079	23.58%

3. Changes in relevant interests

Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows:

s follows:
Date of	Person whose	Nature of change (6)	Consideration given	Class and number	Person's votes
change	relevant interest		in relation to change	of securities	affected
	changed		(7)	affected
		Off market
28/09/2020	Graham JohnMelrose &Olga MaryMelrose	sale of ORDshares, asannounced tothe ASX on 23September	$2.05m	ORD1,576,924	1,576,924
		2020.
	Graham John	Conversion of
30/09/2020	Melrose &Olga Mary	Class DPerformance	Nil	ORD6,075,000	6,075,000
	Melrose	Shares
		Dilution due
		to issue of
30/09/2020	Graham JohnMelrose &Olga MaryMelrose	shares as partof theplacement,which wasannounced to	Nil	ORD40,948,079	40,948,079
		the ASX on
		23/09/2020

604 Page 2 of 3 15 July 2001

4. Present relevant interests

Particulars of each relevant interest of the substantial holder in voting securities after the change are as follows:

Holder ofrelevantinterestGrahamJohnMelrose &Olga MaryMelrose	Registered holderof securitiesGraham JohnMelrose &Olga MaryMelrose	Person entitled to beregistered as holder(8)Graham JohnMelrose & OlgaMary Melrose	Nature of relevantinterest (6)Jointshareholders	Class and numberof securities40,948,079ORD	Person's votes40,948,079

5. Changes in association

The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the substantial holder in relation to voting interests in the company or scheme are as follows:

Name and ACN/ARSN (if applicable)	Nature of association
Not applicable

6. Addresses

The addresses of persons named in this form are as follows:

Name	Address
Graham John Melrose &Olga Mary Melrose	21 Caladenia Parade, Claremont WA 6010

Signature

print name Graham John Hamilton Melrose capacity Shareholder sign here date 30 / 09 / 2020

DIRECTIONS

• (1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 6 of the form.

• (2) See the definition of "associate" in section 9 of the Corporations Act 2001.

• (3) See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.

• (4) The voting shares of a company constitute one class unless divided into separate classes.

• (5) The person's votes divided by the total votes in the body corporate or scheme multiplied by 100.

• (6) Include details of:

  • (a) any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and

  • (b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or

604 Page 3 of 3 15 July 2001

disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).

See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

• (7) Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.

• (8) If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write "unknown".

• (9) Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.